We're thrilled to announce that Avitus Orthopaedics has successfully raised $5,000,000 in a recent funding round, a significant milestone that will propel our mission to revolutionize orthopaedic care. Founded out of a profound commitment to address unmet clinical needs, Avitus has emerged as a pioneering force in the field of bone and marrow harvesting. Our innovation doesn't stop there; we've expanded our expertise to include advanced techniques for bone infection debridement, focusing on the challenging aspects of pseudomembrane and biofilm management during periprosthetic joint infections (PJI) and osteomyelitis/tumor curettage. With our latest advancements in percutaneous autogenous graft delivery, we are truly transforming minimally invasive surgical (MIS) options for bone and marrow harvesting, debridement, and autograft delivery.
This influx of funding will enable us to accelerate the development of our cutting-edge technologies, enhance our product offerings, and ultimately improve patient outcomes in orthopaedic surgeries. We are dedicated to equipping surgeons with the tools they need to effectively manage complex surgical challenges, thereby enhancing recovery times and patient satisfaction. We invite you to learn more about our innovative products and how they are changing the landscape of orthopaedic medicine by visiting our website. Together, we are not just fixing bones; we are fostering a future where surgical interventions are more effective, less invasive, and more beneficial for patients worldwide. Thank you for your continued support as we embark on this exciting journey!
